scholarly article | Q13442814 |
P2093 | author name string | Shuangge Ma | |
Mengyun Wu | |||
Shuaichao Wang | |||
P2860 | cites work | Identification of DBC1 as a transcriptional repressor for BRCA1 | Q24299659 |
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination | Q24652965 | ||
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression | Q26800112 | ||
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer | Q27851654 | ||
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer | Q27851720 | ||
Cancer genes and the pathways they control | Q28275089 | ||
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
Gamma-secretase composed of PS1/Pen2/Aph1a can cleave notch and amyloid precursor protein in the absence of nicastrin | Q28595013 | ||
Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis. | Q31089944 | ||
EGFR and cancer prognosis | Q34399312 | ||
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes | Q34667055 | ||
The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma | Q35105594 | ||
Risk Factors of Non-Hodgkin Lymphoma | Q35499320 | ||
survcomp: an R/Bioconductor package for performance assessment and comparison of survival models | Q35526651 | ||
Multi-modal multi-task learning for joint prediction of multiple regression and classification variables in Alzheimer's disease | Q35592787 | ||
Expression of ETV6/TEL is associated with prognosis in non-small cell lung cancer. | Q35632227 | ||
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. | Q35643852 | ||
ETV6: a versatile player in leukemogenesis. | Q36096564 | ||
PD-1 and BTLA and CD8(+) T-cell "exhaustion" in cancer: "Exercising" an alternative viewpoint | Q36194853 | ||
DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of osteosarcoma | Q36273633 | ||
ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex | Q36328085 | ||
Clinical significance of tumor-infiltrating immune cells focusing on BTLA and Cbl-b in patients with gallbladder cancer | Q36467408 | ||
Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically | Q36475757 | ||
NOTCH signaling as a novel cancer therapeutic target | Q36539533 | ||
Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer | Q36616070 | ||
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes | Q36777326 | ||
A novel crosstalk between CCAR2 and AKT pathway in the regulation of cancer cell proliferation | Q37603343 | ||
Targeting notch signaling pathway in cancer: clinical development advances and challenges | Q37696748 | ||
Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer | Q37877648 | ||
Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia. | Q39120062 | ||
NNK activates ERK1/2 and CREB/ATF-1 via beta-1-AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cells. | Q40284301 | ||
AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer | Q40305921 | ||
EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2. | Q40634600 | ||
Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm | Q41557019 | ||
Association of BTLA gene polymorphisms with the risk of malignant breast cancer in Chinese women of Heilongjiang Province | Q45025590 | ||
The pan-cancer analysis of gene expression patterns in the context of inflammation | Q45733279 | ||
Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasis. | Q45985228 | ||
Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis. | Q47204660 | ||
Investigation of model stacking for drug sensitivity prediction. | Q51733516 | ||
Regularized estimation in the accelerated failure time model with high-dimensional covariates. | Q51933180 | ||
Dissecting the sources of gene expression variation in a pan-cancer analysis identifies novel regulatory mutations. | Q52315593 | ||
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. | Q52602405 | ||
CCAR2 deficiency augments genotoxic stress-induced apoptosis in the presence of melatonin in non-small cell lung cancer cells. | Q53030141 | ||
PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers. | Q53486364 | ||
Simultaneous prediction of multiple outcomes using revised stacking algorithms | Q91536176 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P577 | publication date | 2019-08-09 | |
P1433 | published in | Genes | Q5532699 |
P1476 | title | Integrative Analysis of Cancer Omics Data for Prognosis Modeling | |
P478 | volume | 10 |
Q92153663 | Knowledge Generation with Rule Induction in Cancer Omics | cites work | P2860 |
Search more.